Resources from the same session
LBA47 - Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Presenter: Masahiro Tsuboi
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA48 - Community-based mass screening with low-dose CT for lung cancer in Guangzhou
Presenter: Wenhua Liang
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA47 and LBA48
Presenter: Sanjay Popat
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
950O - Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable lung cancer: The INCREASE trial
Presenter: Idris Bahce
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA49 - CANOPY-A: Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)
Presenter: Edward Garon
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 950O and LBA49
Presenter: Noemi Reguart Aransay
Session: Proffered Paper session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast